DURHAM, N.C., Sept. 27, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today that the Company has been invited to present at two upcoming biotech industry conferences, including BioContactQuebec 2012 on October 4, 2012 at the Chateau Laurier, Québec, and the 3rd Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference on Thursday, October 4, 2012, at the New York Academy of Medicine, New York, NY.
